Rules-Based Medicine Rules-Based Medicine (RBM) is a CLIA-certified biomarker testing laboratory specializing in cost-effective, high-quality multiplexing services. Our protein immunoassays benefit drug discovery & development from...
The Jackson Laboratory We help researchers discover treatments, preventions and cures for human disease through the provision of inbred, mutant and genetically engineered mouse models, research services, and comprehensive technical information...
Transgenomic, Inc. Transgenomic, Inc. is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research,...
Genomics Collaborative BioServe provides a comprehensive 'biomaterial to validated data' genomics services platform, helping researchers gain the pre-clinical data for breakthroughs in drug discovery, molecular diagnostics and pharmacogenomics....
Genizon BioSciences Inc. Genizon Biosciences Inc. discovers genes and biomarkers in common diseases using genome wide association studies (GWAS), leveraging its proven and proprietary technology platform and access to patients from the Quebec...
Pharmacogenomics
Genizon offers innovative and unique pharmacogenomics services to the drug development industry, leveraging assets and technologies from its disease gene...
SNP Genotyping
Genizon's SNP genotyping laboratory offers high-throughput, high quality SNP genotyping to the biopharmaceutical industry, research organizations, and...
Integrated Genomics Founded in 1997, Chicago-based Integrated Genomics specializes in research in microbial genomics, biochemistry, and gene expression. Our scientists have broad experience in both in silico and wet lab sequencing, research...
454 Life Sciences, a Roche company 454 Life Sciences, a center of excellence of Roche Applied Science, develops and commercializes the innovative Genome Sequencer system for ultra-high-throughput DNA sequencing. Specific applications include de novo...
70x75 Bead Deposition Device (16 small regions)
The 70x75 Bead Deposition Device (16 small regions) consists of a bottom plate and a top plate. The top plate presses the gasket firmly against the...
70x75 Bead Deposition Device (2 large regions)
The 70x75 Bead Deposition Device (2 large regions) consists of a bottom plate and a top plate. The top plate presses the gasket firmly against the...
70x75 Bead Deposition Device (4 medium regions)
The 70x75 Bead Deposition Device (4 medium regions) consists of a bottom plate and a top plate. The top plate presses the gasket firmly against the...
The ability to respond to ever-evolving consumer at- titudes, regulatory mandates, and scientic discov- eries requires that manufacturers keep their nger on the pulse of the analytical methodologies required to monitor product safety and quality. In light of the ever- growing number of food and supplement ingredients and complex formulations, the ability to detect unique com- pounds and quantify ...
Historically, vaccines are medicines that deliver or generate antigens that induce specic, active, and protective immunity against infectious diseases. Antigens stimulate the immune system to activate cells and organs that induce active immunity, characterized by production of antibodies (humoral immunity) and/or cytotoxic T-cells (cell mediated immunity). Vaccines “train” the body’s immune ...
Recent industry analyst reports predict that worldwide pharmaceutical industry revenues will grow at a compound annual growth rate (CAGR) of 8.58% through 2008. Worldwide biotechnology revenues are expected to grow at a compound annual growth rate of 25.96% through 2008 – this large growth rate is not surprising as many biotechnology and biopharmaceutical companies are just now moving products ...
This pathways resource is designed to facilitate the discovery of new targeted therapies for several common human autoimmune diseases by highlighting the biological pathways they share and the most relevant mouse models and resources available for their study. Inside, you will find the following:
• Schematics of the genetic pathways common to rheumatoid arthritis, asthma, psoriasis, multiple ...
Conducting comprehensive metabolism studies has long been an essential component of a preclinical drug development program. However, numerous factors — including the increased development of protein-derived drugs and the expanded interest in the role of metabolites in safety assessment — are having a significant impact on the regulatory mandates, scope of studies and methodologies employed. In ...
The approval by the Food and Drug Administration (FDA) of the first inhaled insulin combination product for treatment of diabetes represents a milestone in drug delivery. Exubera is an inhaled powder form of recombinant human insulin (rDNA) used in the treatment of adult patients with type 1 and type 2 diabetes and is the first new delivery option introduced since the discovery of insulin in the ...
In March 2006, six normal healthy volunteers par- ticipating in a clinical study in the UK were given an intravenous (IV) dose of an experimental immunother- apeutic as a part of an ascending single dose safety and tol- erability study. Within a few hours of drug administration, all subjects exhibited severe reactions which progressed to multiple organ failure. As a result of the incident, ...
Biotech was “born” in the 1970s. Since that time innovation by biotech pioneers has brought more than 200 medicines and vaccines to fruition for difficult-to-treat indications including oncology, HIV/ AIDs, diabetes, and immune disorders.
Biotech is poised to capitalize on the current challenges confronting Big Pharma: looming patent expirations on blockbuster medicines and a dearth of new ...
Company descriptions and contact
information are quoted
from the company's website or other promotional information. JAZ'D is not responsible for
the accuracy
of this information. Unless specifically noted, JAZ'D is not sponsored by, affiliated with
or otherwise
connected with any of the listed companies.
